SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001140361-22-025608
Filing Date
2022-07-08
Accepted
2022-07-08 16:48:30
Documents
3
Group Members
INNOVIVA MERGER SUB, INC.

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A ny20004305x10_sctota.htm SC TO-T/A 38855
2 EXHIBIT (A)(5)(F) ny20004305x10_exa5f.htm EX-99.(A)(5)(F) 12221
3 ny20004305x10_exa5flogo.jpg GRAPHIC 64036
  Complete submission text file 0001140361-22-025608.txt   141214
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filed by) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 (781) 810-0120
Entasis Therapeutics Holdings Inc. (Subject) CIK: 0001724344 (see all company filings)

IRS No.: 824592913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-90651 | Film No.: 221074867
SIC: 2834 Pharmaceutical Preparations